LC-MS/MS quantitation of metformin, phenformin, and galegine.

TL Traci E. LaMoia
GB Gina M. Butrico
HK Hasini A. Kalpage
LG Leigh Goedeke
BH Brandon T. Hubbard
DV Daniel F. Vatner
RG Rafael C. Gaspar
XZ Xian-Man Zhang
GC Gary W. Cline
KN Keita Nakahara
SW Seungwan Woo
AS Atsuhiro Shimada
MH Maik Hüttemann
GS Gerald I. Shulman
request Request a Protocol
ask Ask a question
Favorite

Plasma or frozen tissue was added to 0.1 mL of water with 0.1% formic acid and 0.15 mL of methanol containing 0.4 μmol of internal standard (D6-metformin for metformin and galegine and D5-phenformin for phenformin). Plasma samples were vortexed, and tissue samples were homogenized followed by centrifugation. The supernatant was dried under a stream of nitrogen gas, resuspended with 0.3 mL of water with 0.1% formic acid, and filtered with a nanosep 100K centrifugal device before LC-MS/MS analysis.

An ESI source with a positive mode was used for the analysis of metformin, phenformin, and galegine, and the ion-pair-dependent parameters were optimized. The optimized parameters are: curtain gas (14 V), collision gas (medium), ionization potential (5,000 V), probe temperature (450 °C), ion source gas 1 (60 V), ion source gas 2 (60 V), and EP (10 V). The other compound-dependent parameters were also summarized in SI Appendix, Table S1 for phenformin, galegine, and D6-metformin. A C8 reverse-phase LiChrosorb HPLC column (100 mm × 3 mm) was used with a mixed solvent of 10 mM ammonium acetate aqueous solution and pure acetonitrile. Concentrations were calculated from the peak area ratios of metformin, phenformin, and galegine vs. their internal standard, according to the corresponding calibration curves.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A